News

Published on 12 Dec 2024 on Insider Monkey · via Yahoo Finance

Here’s Why argenx SE (ARGX) Surged in Q3

Article preview image

PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A copy of the letter can be downloaded here. Given concerns...

Read the rest of the article
NASDAQ.PJFZX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
3 PGIM Mutual Funds to Enhance Your Returns

PGIM, the asset management business of Prudential Financial, Inc., has $1.4 trillion in assets an...

Zacks · via Yahoo Finance 31 Jan 2025
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be...

Zacks · via Yahoo Finance 21 Jan 2025
Is UnitedHealth (UNH) the Most Reliable Dividend Stock to Buy According to Hedge...

We recently compiled a list of the 12 Most Reliable Dividend Stocks To Buy According to Hedge Fun...

Insider Monkey · via Yahoo Finance 14 Jan 2025
Should You Hold Apellis Pharmaceuticals (APLS)?

PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A co...

Insider Monkey · via Yahoo Finance 12 Dec 2024
Here’s PGIM Jennison Health Sciences Fund’s Views on UnitedHealth Group...

PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A co...

Insider Monkey · via Yahoo Finance 12 Dec 2024
Here’s Why argenx SE (ARGX) Surged in Q3

PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A co...

Insider Monkey · via Yahoo Finance 12 Dec 2024
Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be...

Zacks · via Yahoo Finance 29 Nov 2024
Reasons that Lifted Vertex Pharmaceuticals Incorporated (VRTX) in Q2

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of th...

Insider Monkey · via Yahoo Finance 2 Oct 2024
Should You Hold Apellis Pharmaceuticals (APLS)?

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of th...

Insider Monkey · via Yahoo Finance 2 Oct 2024
PGIM Jennison Health Sciences Fund Sold AbbVie (ABBV) in Q2. Here’s Why

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of th...

Insider Monkey · via Yahoo Finance 2 Oct 2024

Copyright Statfolio @ 2025

Social Accounts